Type
. [Borderline-type leprosy]. Zeitschrift fur Hautkrankheiten. 1977;52(6):331-2.
Type
. On the mode of transmission of Mycobacterium leprae. Leprosy review [Internet]. 1977;48(1):9-16. Available from: http://leprev.ilsl.br/pdfs/1977/v48n1/pdf/v48n1a03.pdf
Type
. Surgical management of gross mid-foot damage. Leprosy review [Internet]. 1977;48(1):35-42. Available from: http://leprev.ilsl.br/pdfs/1977/v48n1/pdf/v48n1a06.pdf
Type
. How effective is the treatment of leprosy?. Leprosy review [Internet]. 1977;48(1):3-8. Available from: http://leprev.ilsl.br/pdfs/1977/v48n1/pdf/v48n1a02.pdf
Type
. Phagocytosis in leprosy. I. The levels of "diaphorase", beta-glucuronidase, acid phosphatase, alkaline phosphatase and lipase in circulating leucocytes. Leprosy review [Internet]. 1977;48(1):17-26. Available from: http://leprev.ilsl.br/pdfs/1977/v48n1/pdf/v48n1a04.pdf
Type
Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet (London, England). 1996;348(9019):17-24.
Type
. Soluble adhesion molecules in sera of patients with leprosy: levels of soluble intercellular adhesion molecule-1 (sICAM-1) rapidly decrease during multi-drug therapy. Clinical and experimental immunology. 1996;105(1):65-8.
Type
. Cytomorphology of leprosy across the Ridley-Jopling spectrum. Acta cytologica. 1996;40(4):719-23.
Type
. Hansen's Disease. Southern medical journal. 1996;89(7):647-52.
Type
. [Abrogation of leprosy prevention law and public health]. [Nihon koshu eisei zasshi] Japanese journal of public health. 1996;43(6):423-6.